Tremfya indct 200MG/2ML X2 pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FDA3U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,309
Award facts
- Contract value 100% obligated
- $22,308.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,308.70 to AmerisourceBergen Drug Corp for the supply of Tremfya (guselkumab) 200mg/2ml injectable pens on January 16, 2026, with completion targeted for January 20, 2026. This firm fixed-price, non-set-aside contract represents a pharmaceutical delivery to support federal military and healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement. The company operates as a subsidiary of Cencora, Inc., the parent organization that also conducts business under the AmerisourceBergen name.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, demonstrating AmerisourceBergen's substantial role in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FDA3U?
SPE2DR26FDA3U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FDA3U worth?
The government has obligated $22,309 on SPE2DR26FDA3U.
Is contract SPE2DR26FDA3U an order under another contract?
Yes. SPE2DR26FDA3U is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA3U competed?
The extent of competition for SPE2DR26FDA3U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award